Success Story: NIW Approved After Successful RFE Response for a Postdoctoral Researcher Advancing Early Detection and Treatment of Amyloid Diseases
Client’s Testimonial:
"Thank you, thank you very much!!!”
On February 18th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Biophysics (Approval Notice).
General Field: Biophysics
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: Spain
State of Residence at the Time of Filing: Texas
Approval Notice Date: February 18th, 2026
Processing Time: 7 months, 11 days (Premium Processing Upgrade Requested)
Case Summary:
Drawing on our extensive experience and a proven track record of more than 32,000 successful cases, our team prepared a focused NIW petition and later helped secure approval through a successful RFE response.
The client, who holds a Ph.D. in neuroscience, works at a U.S. medical research institution and proposed to continue research at the intersection of biophysics and neurodegenerative disease. The endeavor centered on characterizing patient-derived ex vivo fibrils using cryogenic electron microscopy to support the development of more specific early detection methods and treatments, with the goal of improving patient outcomes and reducing the substantial economic and societal burden associated with amyloid diseases. In the petition, we framed this work not as a narrow laboratory study, but as research with direct relevance to pressing U.S. healthcare needs.
We emphasized that the proposed endeavor had both substantial merit and national importance because it addressed major barriers in diagnosing and treating amyloid-related diseases, including Alzheimer’s disease. The petition explained that structural characterization of patient-derived fibrils can help clarify disease mechanisms, improve precision in therapeutic targeting, and strengthen prospects for earlier detection and better treatment design. We also showed why this mattered at the national level by connecting the client’s work to the rising number of Americans expected to live with Alzheimer’s disease and the enormous projected cost burden on the U.S. healthcare system. That framing helped show an adjudicator why this research had significance beyond the client’s own lab or employer.
We also highlighted the client’s strong research record in a way that spoke to reliability, originality, and peer recognition rather than simply listing raw numbers. The client had authored 7 peer-reviewed journal articles, 2 conference abstracts, 5 preprints, and 3 book chapters. Those publications showed sustained productivity across multiple formats, while the first-authored and co-first-authored work helped demonstrate a leading role in generating and communicating important findings. The client’s published work had also received 219 citations, which we treated as evidence that other researchers were relying on the client’s results in their own investigations. The petition further strengthened this point by showing that several papers had performed at notably high citation percentiles for their year and field, which is the kind of context that helps an adjudicator see that the influence is meaningful rather than merely numerical.
Beyond publication and citation evidence, the record showed additional signs that the client was well-positioned to advance the endeavor. The client had completed at least 1 peer review, which supported the argument that other experts trusted the client’s judgment in evaluating research in the field. The petition also pointed to funding support connected to the Welch Foundation, which served as an objective indicator that the research area itself had attracted meaningful institutional backing. Together, these factors helped us present the client as someone whose expertise had already been recognized by the broader scientific community and whose work had momentum behind it.
We are delighted to share that the I-140 NIW petition was approved after a successful RFE response. It was a privilege to support this case and to help present the client’s record in a way that clearly explained both the scientific value of the research and its broader importance to the United States. We extend our sincere congratulations and best wishes for the client’s continued success in advancing research that may improve early detection and treatment strategies for amyloid diseases.